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Purpose: It has been suggested that leukocyte trapping and activation in the mierocircu- 
lation of the leg skin causes lipodermatosclerosis and ulceration in patients with chronic 
venous disease. Ambulatory venous hypertension is accepted as the physiologic factor 
that leads to ulceration. We investigated leukocyte ndothelial dhesion in patients who 
were subjected to short-term venous hypertension. 
Methods: Two groups of patients with venous disease were studied: group 1, varicose veins 
with skin changes (n = 15); and group 2, varicose veins without skin changes (n = 15). 
Blood samples were taken from a foot vein before and after standing for 30 minutes to 
raise the venous pressure in the lower limb, and after lying supine again for 10 minutes. 
The samples were analyzed for leukocyte surface CD11b and L-selectin (CD62L) expres- 
sion using a flow cytometer. Plasma-soluble L-selectin was also measured using an 
enzyme-linked immunosorbent assay. 
Results: In patients with skin changes, median eutrophil CD l lb  levels fell from 4.66 to 
3.83 arbitrary units (p = 0.005, Wilcoxon) after 30 minutes of venous hypertension. 
Median monocyte CD11b levels fell from 7.65 to 5.8 arbitrary units (p = NS, Wilcoxon) 
after venous hypertension and then fell further to 5.43 arbitrary units (p = 0.02 vs 
baseline; Wilcoxon) when the venous hypertension wasremoved. Neutrophil and mono- 
cyte L-selectin levels also fell in response to venous hypertension, remaining low even 
after venous hypertension was removed. A similar pattern was seen in patients with 
uncomplicated varicose veins. There was a rise in soluble L-selectin in the plasma of both 
groups of patients after venous hypertension, reflecting leukocyte adhesion to endothe- 
lium. In the group of patients with skin changes the level of soluble L-selectin rose from 
695 ng/ml to 836 ng/ml (p = 0.02, Wilcoxon), and in the group without skin changes 
the rise was from 700 ng/ml to 801 ng/ml (p = 0.02, Wilcoxon). 
Conclusion: Venous hypertension results in sequestration f the more activated population of 
neutrophils and monocytes in the microcirculation f the leg in patients with venous disease. 
These cells bind to the endothelium, releasing L-selectin, a d do not emerge from the limb 
when venous hypertension is reversed. These findings do not differ between patients with 
varicose veins and those with skin changes. (J Vasc Surg 1997;25:265-73.) 
The cause of skin damage in patients with chronic 
venous disease is incompletely understood. In 1987 
Moyses et al. 1 reported a reduction in the number of 
white cells leaving the feet in eight healthy subjects 
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during a 45-minute period of experimental venous 
hypertension. Thomas et al.2 found a larger fall in a 
group of 10 patients with chronic venous insuffi- 
ciency and concluded that leukocytes were being 
sequestered in the lower limb. Coleridge Smith et 
al? showed using video microscopy that the number 
of  visible capillaries fell during a period of  venous 
hypertension, suggesting that increased venous pres- 
sure reduced the capillary perfusion pressure and 
hence the capillary flow rate. On the basis of these 
observations, the white cell trapping hypothesis 3 was 
proposed, which suggests that raised venous pressure 
led to decreased flow, in turn causing leukocyte mar- 
gination, activation, adhesion, and extravascular mi- 
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Fig. 1. White cell:red cell ratio during the experiment. Descriptors are medians and interquar- 
tile ranges, statistics are Wilcoxon matched pairs signed rank test. B, Basal; S, standing; L, lying. 
Table I. Duplex findings in patients 
No. of Mean age 
patients (range) (yr) SVI DVI + (SVI) Postthrombotic 
LDS 8F/  51 (32 to 69) 3 12 (10) 10 
7M 
W 7F/ 48 (29 to 73) 13 2(2) 1 
8M 
SVI, Superficial venous incompetence; DVI, deep venous incom- 
petence. 
gration. The release of proteolytic enzymes and free 
radicals from activated leukocytes was thought to 
result in tissue damage. This finding was supported 
by histologic evidence of white cell infiltration of the 
tissues 4 in skin biopsies from patients with venous 
disease. 
The molecular mechanism of leukocyte adhesion 
to vascular endothelial cells is characterized by a 
series of steps. Many adhesion molecules are ex- 
pressed by circulating leukocytes and endothelial 
cells in response to physiologic and pathologic stim- 
uli. These adhesion molecules are broadly divided 
into three groups: the selectins, the integrins, and the 
immunoglobulin superfamily. A complex interplay of 
physical, biologic, and biochemical factors control 
and modulate leukocyte-endothelial cell adhesion, 
leading to leukocyte migration from the circulation 
into the tissues. Normally leukocytes express a sur- 
face adhesion molecule called L-selectin that binds 
loosely to receptors on the vascular endothelium and 
results in "rolling" ofneutrophils along the endothe- 
lium. On activation of leukocytes, L-selectin is shed 
and a second stage receptor, the integrin CDl lb ,  is 
expressed by leukocytes. This allows firm adhesion of 
leukocytes to the endothelium and subsequent de- 
granulation or extravascular migration, s The number 
of CD l lb  molecules expressed on the cell surface 
is dependent on the state of cell activation. Some 
white blood cells are reversibly bound to the endo- 
thelium and reenter the systemic irculation when 
venous pressure is lowered. Granulocytes are able 
to rapidly upregulate surface integrins from intra- 
cellular stores. 
We have previously demonstrated evidence of 
increased neutrophil degranulation i normal sub- 
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Fig. 2. Neutrophil surface CD11b expression expressed, as mean cell f uorescence in arbitrary 
units before, during, and after venous hypertension produced by standing for 30 minutes. 
Descriptors are medians and interquartile ranges, statistics are Wilcoxon matched pairs signed 
rank test. B, Basal; S, standing; L, lying; NS, not significant. 
jeers 6'7 and patients with chronic venous disease x- 
posed to short-term venous hypertension. 8 We have 
reported increased expression of the integrin 
CDl lb /CD18 in normal volunteers ubjected to 
short-term venous hypertension. We have also inves- 
tigated in vivo leukocyte migration in volunteers 
during short-term venous hypertension using the 
"skin window technique. ''9 Leukocyte migration in 
the tissue decreased after experimental venous hyper- 
tension. 10 
The aim of our present study was to assess 
whether patients ubjected to short-term venous hy- 
pertension showed evidence of neutrophil and 
monocyte activation and whether endothelial bind- 
ing occurred. As a measure of activation, we assessed 
cell surface xpression of the integrin CDl lb  and the 
selectin CD62L on neutrophils and monocytes. 
Plasma levels of L-selectin, which is shed by leuko- 
cytes on activation, were measured as an index of 
leukocyte-endothelial adhesion. 
MATERIAL  AND METHODS 
The study was approved by the local ethics com- 
mittee, and informed consent was obtained. Thirty 
patients (15 male, 15 female; mean age, 50 years; 
range, 29 to 73 years) with chronic venous disease 
demonstrated by color duplex ultrasonography and 
photoplethysmography volunteered for inclusion in 
the study. The patients were further subdivided into 
two groups of 15 patients classified according to the 
severity of their disease (group 1, lipodermatosclero- 
sis or hemosiderosis skin changes present, Hawaii 
clinical stage 4 [LDS]; group 2, skin change absent, 
Hawaii clinical stage 2 [VV]). 11 The duplex findings 
in the two groups are summarized in Table I. Pa- 
tients with a history or clinical evidence of coexistent 
arterial disease, diabetes mellitus, connective tissue 
disorders including rheumatoid arthritis, blood dis- 
orders, infection within the previous 6 weeks, or 
medication known to alter white cell activity were 
excluded from the study. 
}'OURNAL OF VASCULAR SURGERY 
268 Saharay et al. August 1997 
12- p=Wi lcoxon 
2) 
9 
!° 
0 
= 3 
0 
p=ns 
- ' ' p=O.O05 
,p=O.O02 
, p=O.07 , 
LDS VV 
B S L B S L 
Fig. 3. Neutrophil surface CD62L expression expressed asmean cell fluorescence in arbitrary 
units before, during, and after venous hypertension produced by standing for 30 minutes. 
Descriptors are medians and interquartile ranges, statistics are Wilcoxon matched pairs signed 
rank test. 13, Basal; S, standing; L, lying; NS, not significant. 
Procedure. A 18G cannula (Vasculon 2, Viggo- 
Spectramed, Helsingborg, Sweden) was placed in the 
distal ong saphenous vein or dorsal foot vein of one 
leg. The cannula was flushed with heparinized saline 
solution, and the patient rested supine on a couch for 
20 minutes, after which 2 ml of blood was taken and 
discarded from the cannula, mad a further 10 ml was 
collected into two tubes containing ethylenediamine 
tetraacetic acid and one tube containing citrate 
(Vacutainer, Becton Dickinson Vacutainer Systems 
Europe, BP No 37-38241 Meylan Cedex, France). 
The patient then stood supported against the side of 
the couch for 30 minutes without moving the calf 
muscles (it was previously shown by the authors by 
direct pressure measurement that this raises the ve- 
nous pressure in the superficial veins of the leg to 
between 70 and 80 mm Hgl2), and a second blood 
sample was taken at the end of this period. The 
volunteer then returned to he supine position and a 
third sample was taken after 10 minutes. Blood sam- 
ples were carefully placed directly into the sample 
tubes after removing the stoppers to prevent exces- 
sive cell agitation. 
A full blood count, including a differential count, 
was performed on all patients (Sysmex SE-9000, 
Sysmex (UK) Ltd., Milton Keyncs, U.K.). Neutro- 
phil and monocyte CD1 lb and L-selectin expression 
were measured by a whole blood assay using citrated 
blood and fluorescent-labeled monoclonal antibod- 
ies (CDllb,  catalog no. 347557; control, catalog 
no. 349053, Becton Dickinson, Oxford, U.K.; L- 
selectin, catalog no. 1231; control, catalog no. 0639, 
Immunotech, Birmingham, U.K.) in a flow cytome- 
ter. All samples were analyzed immediately after the 
experiment was completed. The same protocol and 
settings were used on the flow cytometer (Coulter 
EPICS Elite, Coulter Electronics Ltd., Luton, U.K.) 
for the whole group of patients. Plasma from an 
ethylenediamine tetraacetic acid sample was sepa- 
rated by centrifugation a d stored at -20 ° C. Plasma 
L-selectin was measured by a commercially available 
enzyme-linked immunosorbent assay (R & D Sys- 
tems Europe, Oxon, U.K.) once all the samples were 
collected. 
Analysis of data. The statistical package for the 
social sciences (SPSS, Chicago, Ill.) was used to ana- 
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Fig. 4. Monocyte surface CDllb expression expressed as mean cell fluorescence in arbitrary 
units before, during, and after venous hypertension produced by standing for 30 minutes. 
Descriptors are medians and interquartile ranges, statistics are Wilcoxon matched pairs signed 
rank test. B, Basal; S, standing; L, lying; NS, not significant. 
lyze thc data, and nonparametric tests for paired and 
unpaired ata (Wilcoxon matched pairs signed rank 
test and Mann-Whitney U test) were used. The dif- 
ference between medians and 95% confidence inter- 
val were calculated using Wilcoxon method confi- 
dence interval analysis (BMJ, London). All results are 
described as median (interquartile range, IQR). 
RESULTS 
Full blood count on samples taken during the 
experiment showed a rise in the hemoglobin, red cell 
count, white cell count, and hematocrit level on 
standing, which returned toward normal on resum- 
ing the supine position. The magnitude of the in- 
crease in white cell numbers during standing was less 
than that of the hemoglobin, red cell count, or he- 
matocrit level. Leukocyte trapping during the exper- 
iment was confirmed by calculating the white cell:red 
cell ratio, which is shown in Fig. 1. In both groups of 
patients the white cell:red cell ratio fell significantly 
in response to venous hypertension. On returning to 
the supine position there was a significant increase in 
the white cell:red cell ratio, indicating etflux ofleuko- 
cytes that were trapped in the limb during the venous 
hypertensive phase. 
Leukocyte CDl lb  and L-selectin expression. 
Neutrophil CDI lb  levels (expressed as mean cell 
fluorescence in arbitrary units) for the experiment arc 
shown in Fig. 2. In patients with LDS there was a 
significant fall in CD 11 b expression after 30 minutes 
of standing, followcd by a further nonsignificant fall 
on returning to the supine position. In patients with 
VVs there was a similar fall in CDI lb expression after 
venous hypertension, which fell further when the 
hypertensive challenge was withdrawn. Fig. 3 shows 
the corresponding neutrophil L-selectin levels in the 
same patient groups. In both groups we noted a 
significant sustaincd fall in neutrophil surface L-se- 
lectin expression, throughout the entire period. 
Monocyte CDI lb  levels for the experiment are 
shown in Fig. 4. In patientg with LDS there was a fall 
in CDl lb  expression after 30 minutes of standing, 
which did not reach statistical significance. However, 
monocyte CDl lb  expression fell further when ve- 
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Fig. 5. Monocyte surface CD62L expression expressed as mean cell fluorescence in arbitrary 
units before, during, and after venous hypertension produced by standing for 30 minutes. 
Descriptors are medians and interquartile ranges, statistics are Wilcoxon matched pairs signed 
rank test. B, Basal; S, standing; L, lying; NS, not significant. 
Table II, A. Neutrophil and monocyte surface CDl lb  expression 
Patients 
Controls LDS VV 
Mean cell 
fluorescence (AU) Neutrophils Monocytes Neutrophi ls  Monocytes Neutrophils Monocytes 
Basal 4.31" t 6.08" t 4.66" t 7.65"1" 4.67" t 6.63" t
Standing 3.13" 3.85* 3.83* 5.80* 3.45* 4.83* 
Lying 5.671 ~ 5.07"[ 3.83 t 5.43 t 3.261" 4.00 t
95% CI, Wilcoxon *0.54 to 1.97 "1.11 to 2.64 *0.32 to 2.43 *-1.62 to 4.49, NS *0.52 to 1.82 "1.24 to 5.86 
t -5 .92  to -0.26 t -0 .79  to 1.56, NS t0.41to 3.15 t l .06to  5.07 t0.86to 1.86 1-1.28 to 5.52 
C/, Confidene interval, Wilcoxon method; NS, not significant. 
nous hypertension was reversed. Similarly, in patients 
with VVs monocyte CDl lb  expression fell signifi- 
cantly after venous hypertension and then when the 
hypertensive challenge was withdrawn. Monocyte L- 
selectin levels in both groups showed a significant 
sustained fall (Fig. 5). 
Plasma L-selectin. Plasma L-selectin levels are 
shown in Fig. 6. There was a significant rise in solu- 
ble L-selectin in the plasma of both groups of pa- 
tients after venous hypertension. 
These results suggest hat leukocyte activation 
occurred in response to venous hypertension result- 
ing in shedding of  surface L-selectin and hence the 
rise seen in the plasma. By definition, activated leu- 
kocytes are adherent to the endothelium and hence 
not assayed, which was reflected in the fall in CD1 lb 
after venous hypertension. In patients CDl lb  ex- 
pression remained low even after the hypertensive 
insult was withdrawn. This is in contrast o our pre- 
vious finding in normal control subjects, where we 
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Fig. 6. Soluble CD62L in plasma in ng/ml before, during, and after venous hypertension 
produced by standing for 30 minutes. Descriptors are medians and interquartile ranges, 
statistics are Wilcoxon matched pairs signed rank test. B, Basal; S, standing; L, lying; NS, not 
significant. 
Table I I ,  B. Neutrophil and monocyte surface CD62L expression 
Patients 
Controls LDS VV 
Mean cell 
fluorescence (AU) Neutrophils Monocytes Neutrophils Monocytes Neutrophils Monocytes 
Basal 4.10" 7 1.38"7 6,48*7 
Standing 3.71" 1.08" 5,95* 
Lying 3.597 1.257 5,077 
95% CI, Wilcoxon *-0.02 to 0.72, NS "0.01 to 0.50 *-0.15 to 0.46, NS 
1-0.19 to 1.35 7-0.05 to 0.53, NS 70.27 to 0.99 
3.22"{ 5.58" t 3.03"} 
2.52* 5.36* 2.96* 
2.76 t 4.73 t 2.50 t
*0.06 to 0.73 *0.22 to 0.61 *-0.01 to 0.35 
t0.29 to 1.28 1"0.38 to 0.91 t0.28 to 0.67 
C/, Confidence interval, Wilcoxon method; NS, not significant. 
noted increased CDl lb  expression after reversal of 
the venous hypertension. 13 There was no significant 
difference between the two groups of patients. 
The results, including previously published ata 
on normal control subjects, are summarized in Ta- 
bles II and III. 
D ISCUSSION 
Chronic venous insufficiency and its sequelae, 
such as lipodermatosclerosis and venous ulceration, 
is a major healthcare problem in the Western World. 
Two recent surveys in Great Britain have calculated 
the prevalence of venous ulceration as 0.18% and 
0.148% respectively. 143s In the United Kingdom 
alone, more than £600 million is spent annually to 
care for patients who have venous ulcers. 16 Much of 
this is spent on care in the community, with 30% of 
community nursing time spent on treating leg ulcers. 
The precise sequence of events that results in skin 
damage in patients who have chronic venous disease 
272 Saharay et al. 
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Table III. Soluble CD62L in plasma 
in ng/ml  
Patients 
Median (ng/ml) Controls LDS VV 
Bas~ 886* 695* 700* 
Stan~ng 1064" 836* 801" 
Lying 957 708 769 
95% CI, Wilcoxon "251to 154 *252 to 17.5 "130 to 52 
C/, Confidence interval, Wilcoxon method; NS, not significant. 
is currently unl~aown. Recently the "white cell trap- 
ping hypothesis" has been proposed, which suggests 
that raised venous pressure causes leukocyte activa- 
tion, adhesion, and extravascular migration, with the 
release of proteolytic enzymes and free radicals re- 
sulting in tissue damage. Dutrochet 17 first reported 
in 1824 that white cells became adherent o the 
vessel walls and emigrated to the tissues. Leul¢ocytes 
express adhesion-promoting receptors that mediate 
cell-cell and cell-matrix interaction. These interac- 
tions are crucial for the direction and control of 
leukocyte traffic, migration through tissues, and the 
development ofimmune and nonimmune inflamma- 
tory responses. Several families of adhesion receptors 
have been identified, of which the main are the inte- 
grin and immunoglobulin superfamilies and the se- 
lectins. The leukocyte integrin family consists of 
three c~[3 heterodimeric membrane glycoproteins, 
which share a common [3 subunit, CD18. The oL 
subunits of the three members are designated 
CDl la ,  b, and c. Once assembled, these adhesion 
molecules are either transported to the cell surface or 
stored in peroxidase-negative granules (normally 
about 60%). 18 Leukocytes are able to upregulate sur- 
face integrins rapidly from intracellular stores-- 
within minutes at 37 ° C, which is independent of 
protein or messenger RNA synthesis. There are two 
further members of the integrin family: the VLA 
(very late activation antigens), which appear late in T 
cell activation, and the cytoadhesins, which are found 
on platelets and endothelial cells and bind extracellu- 
lar matrix proteins. The selectins are characterized 
by a common lectin domain and are a group of 
three integral membrane glycoproteins. E-selectin 
(CD62E) is expressed by endothelial cells, P-selectin 
(CD62P) by both endothelial cells and platelets, and 
L-selectin only by leukocytes. The current heory of 
white cell adhesion is a two-step model) 9 Normally 
leukocytes express urface adhesion molecules called 
L-selectin, which bind loosely to receptors on the 
vascular endothelium, resulting in marginating leu- 
kocytes to "roll" along the endothelium. Recently 
the participation of P-selectin and E-selectin in leu- 
kocyte rolling has also been reported. 2° This gives 
the circulating leukocytes a chance to examine the 
endothefium ore closely, although the binding is 
temporary and is easily broken down by shear stress. 
In the presence of endothelial damage or other local 
stimulus, leukocytes hed L-selectin and express a 
second-stage r ceptor, the integrin CDl lb ,  which 
then binds to counter ligands on the vascular endo- 
thelium and lead to degranulation or extravascular 
migration. 21 
On investigating this phenomenon, we found 
that in patients who have chronic venous disease 
there was a fall of both CD1 lb and L-selectin expres- 
sion on circulating neutrophils and monocytes in 
response to venous hypertension. The explanation 
for this is that the circulating population of leuko- 
cytes exhibits a range of activation, reflected as a 
range of expression of the surface ligands. Previous 
work suggests that leukocyte populations are not 
homogeneous 22 and consist of a "primed" and 
"unprimed" group. Leukocytes most likely to bind 
to endothelium represent he "primed" group, 
which express the highest levels of CD l lb  and L- 
selectin. Therefore, the fall in the mean cell fluores- 
cence of the circulating cells is the result of the more 
activated cells adhering to the endothelium. Surface 
expression of CD l lb  and L-selectin remained low 
even after the venous hypertensive insult was with- 
drawn. At the same time, we noted a rise in the 
soluble L-selectin levels in the plasma, confirming it 
had been shed, a process that precedes CDl lb  ex- 
pression and firm adhesion. 23 These findings, consid- 
ered together, provide strong evidence of leukocyte 
activation and trapping in the microcirculation. We 
had previously investigated leukocyte activation in 
normal controls and noted an initial fall in leukocyte 
CD1 lb and L-selectin expression i  response to ve- 
nous hypertension, which was followed, in contrast 
to the patient groups, by a rise in CD1 lb expression 
after the hypertensive insult was withdrawn. 1~ The 
likely explanation is that in normal volunteers leuko- 
cyte-endothelial adhesion is easily reversible, as there 
is no endothelial damage, as compared with patients 
where it is largely irreversible in the "primed" group 
as a result of both endothelial damage and increased 
leukocyte activation, and only a subpopulation that 
are "unprimed" are released back into the circula- 
tion. Naturally occurring blocldng antibodies to 
CD1 lb /CD18 receptors have been reported, 24,2~ 
and it may be that patients with long-standing 
chronic venous disease release acirculating inhibitory 
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factor that binds to and blocks CDl lb /CD18 re- 
ceptors of activated leukocytes, thereby preventing 
adhesive interaction. Because these receptors are 
blocked, they are not detected in our assay. 
There appears to be no difference in response to 
venous hypertension in the two groups of patients 
with venous disease. Although the behavior of the 
leukocytes tudied differs from those in control sub- 
jects, this does not provide an explanation of why 
skin changes develop in one group of  patients and 
not in others. Presumably, other aspects of the re- 
sponse of the tissues to leukocyte adhesion are in- 
volved in the development of sldn damage. 
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